Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine with or without dobutamine in pediatric septic shock
IRCT20101220005426N13Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of norepinephrine and dobutamine in septic shock (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Mortality and Morbidity. Started Jan 2023; status: completed.
02
Drugs
norepinephrinedobutamine
03
Conditions
septic shock
Beyond the preview
Go deeper on IRCT20101220005426N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101220005426N13.